Press Release – INDIVA has been added to the OTCQX Cannabis Index

Not for distribution to U.S. Newswire Services or for dissemination in the United States.

INDIVA

INDIVA has been added to the OTCQX Cannabis Index

LONDON, ON – (June 5, 2019): INDIVA Limited (the “Company” or “Indiva“) (TSXV:NDVA) (US:NDVAF) is pleased to announce that the Company has been added to OTC Markets Group new OTCQX® Cannabis Index (.OTCQXMJ). The index will act as a performance benchmark for cannabis companies which trade on the OTCQX Best Market.

The OTCQX Cannabis Index features a diverse group of high-quality cannabis companies that meet strict financial, disclosure, and corporate governance standards as well as meeting a minimum liquidity screen. As of May 31st, approximately 56 cannabis-related securities are trading on the OTCQX Market. 30 of these securities, Indiva included, have been chosen for the new OTCQX Cannabis Index.

 

About Indiva

Indiva aims to become a house of global marijuana brands, recognized for high quality cannabis products. Indiva’s wholly owned subsidiary is licensed under the Cannabis Act. As marijuana laws liberalize in Canada and internationally, Indiva will expand its product offering to include safe edibles and other client-friendly cannabis products. In Canada, Indiva will produce and distribute Ruby Cannabis Sugar, Sapphire Salt, Ruby Gems, as well as award winning Bhang Chocolate and other derivative products through license agreements and joint-ventures respectively. In addition, as marijuana laws liberalize internationally, Indiva will use its Canadian operations as a platform to open new markets for its cannabis products.

 

Contact Information

Niel Marotta, CEO, INDIVA
Phone: 613-883-8541
Email: [email protected]

Steve Low, Investor Relations
Phone: 647-620-5101
Email: [email protected]

 

DISCLAIMER & READER ADVISORY

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the Transaction and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to obtain the necessary regulatory and other third parties approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

 

subscribe to news